| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.56 | 0.06 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.42 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.36 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.16 | 0.06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.2 |